Use of Medicare-subsidised treatment services among people prescribed opioids for chronic non-cancer pain.

IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Ria E Hopkins, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Milton Cohen, Fiona Blyth, Natasa Gisev
{"title":"Use of Medicare-subsidised treatment services among people prescribed opioids for chronic non-cancer pain.","authors":"Ria E Hopkins, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Milton Cohen, Fiona Blyth, Natasa Gisev","doi":"10.1071/PU24012","DOIUrl":null,"url":null,"abstract":"<p><p>Objectives Australians receive healthcare services subsidised by the Medicare national health insurance scheme, including through the Chronic Disease Management Initiative supporting primary care management of chronic conditions. The use of such subsidised services by people with chronic non-cancer pain (CNCP) is unknown. This study examined Medicare-subsidised service use, including Chronic Disease Management items, allied health service use, and specialist attendances, among Australians prescribed opioids for CNCP. Methods Medicare Benefits Schedule claims data for the period 1 January 2012-31 December 2018 were linked to a longitudinal cohort of 1206 adults prescribed opioids for CNCP. Service use was compared with the general population to examine whether individuals with CNCP make greater use of such services and factors associated with service use (including demographics, socioeconomic status, pain scores and opioid treatment characteristics, and physical and mental health scores) were examined. Results Use of primary, allied health, and specialist services among adults with CNCP was high when compared with the general population. Over 3years, 928 participants (76.9%) received Chronic Disease Management items, mostly care plans (n =825, 68.4%). Private health insurance and living in a major city were associated with increased odds and rates of any specialist and pain medicine specialist attendances (private insurance and specialist attendances: adjusted odds ratio 4.29, 99.5% confidence interval 2.32-7.91; major city and pain specialist attendances: adjusted incident rate ratio 1.70, 99.5% confidence interval 1.12-2.56). Conclusions Australians prescribed opioids for CNCP have a high use of subsidised primary, allied health, and specialist services. However, sociodemographic disparities were apparent, and there remains a need to improve specialist service accessibility for Australians who are uninsured and living in regional/remote areas. There is also a need to evaluate whether care delivered through current Medicare initiatives is meeting the needs of Australians with CNCP.</p>","PeriodicalId":45898,"journal":{"name":"Public Health Research & Practice","volume":"35 ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Research & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1071/PU24012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives Australians receive healthcare services subsidised by the Medicare national health insurance scheme, including through the Chronic Disease Management Initiative supporting primary care management of chronic conditions. The use of such subsidised services by people with chronic non-cancer pain (CNCP) is unknown. This study examined Medicare-subsidised service use, including Chronic Disease Management items, allied health service use, and specialist attendances, among Australians prescribed opioids for CNCP. Methods Medicare Benefits Schedule claims data for the period 1 January 2012-31 December 2018 were linked to a longitudinal cohort of 1206 adults prescribed opioids for CNCP. Service use was compared with the general population to examine whether individuals with CNCP make greater use of such services and factors associated with service use (including demographics, socioeconomic status, pain scores and opioid treatment characteristics, and physical and mental health scores) were examined. Results Use of primary, allied health, and specialist services among adults with CNCP was high when compared with the general population. Over 3years, 928 participants (76.9%) received Chronic Disease Management items, mostly care plans (n =825, 68.4%). Private health insurance and living in a major city were associated with increased odds and rates of any specialist and pain medicine specialist attendances (private insurance and specialist attendances: adjusted odds ratio 4.29, 99.5% confidence interval 2.32-7.91; major city and pain specialist attendances: adjusted incident rate ratio 1.70, 99.5% confidence interval 1.12-2.56). Conclusions Australians prescribed opioids for CNCP have a high use of subsidised primary, allied health, and specialist services. However, sociodemographic disparities were apparent, and there remains a need to improve specialist service accessibility for Australians who are uninsured and living in regional/remote areas. There is also a need to evaluate whether care delivered through current Medicare initiatives is meeting the needs of Australians with CNCP.

在处方阿片类药物治疗慢性非癌症疼痛的人群中使用医疗保险补贴的治疗服务。
澳大利亚人获得医疗保险国家健康保险计划补贴的保健服务,包括通过慢性病管理倡议支持慢性病的初级保健管理。慢性非癌性疼痛(CNCP)患者使用这种补贴服务的情况尚不清楚。这项研究调查了澳大利亚人为CNCP处方阿片类药物的医疗补贴服务使用情况,包括慢性病管理项目、联合卫生服务使用情况和专家出诊情况。方法:2012年1月1日至2018年12月31日期间的医疗保险福利计划索赔数据与1206名患有CNCP的成人阿片类药物的纵向队列相关联。将服务使用与一般人群进行比较,以检查CNCP患者是否更多地使用此类服务,并检查与服务使用相关的因素(包括人口统计学、社会经济地位、疼痛评分和阿片类药物治疗特征,以及身心健康评分)。结果与一般人群相比,CNCP成人的初级、联合健康和专科服务的使用率很高。在3年中,928名参与者(76.9%)接受了慢性病管理项目,主要是护理计划(n =825, 68.4%)。私人医疗保险和居住在大城市与任何专科医生和止痛药专科医生出诊的几率和比率增加相关(私人保险和专科医生出诊:调整优势比4.29,99.5%置信区间2.32-7.91;主要城市和疼痛专科出勤:调整后的事故率比1.70,99.5%可信区间1.12-2.56)。结论:澳大利亚人为CNCP开具阿片类药物处方,对补贴的初级、联合卫生和专科服务的使用率很高。然而,社会人口差异是明显的,仍然需要改善没有保险和生活在区域/偏远地区的澳大利亚人获得专家服务的机会。还需要评估通过当前医疗保险计划提供的护理是否满足患有CNCP的澳大利亚人的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Public Health Research & Practice
Public Health Research & Practice PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
6.70
自引率
0.00%
发文量
51
审稿时长
20 weeks
期刊介绍: Public Health Research & Practice is an open-access, quarterly, online journal with a strong focus on the connection between research, policy and practice. It publishes innovative, high-quality papers that inform public health policy and practice, paying particular attention to innovations, data and perspectives from policy and practice. The journal is published by the Sax Institute, a national leader in promoting the use of research evidence in health policy. Formerly known as The NSW Public Health Bulletin, the journal has a long history. It was published by the NSW Ministry of Health for nearly a quarter of a century. Responsibility for its publication transferred to the Sax Institute in 2014, and the journal receives guidance from an expert editorial board.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信